Showing results (391-400 of 468) with videos related to

Sort By:
Pageof 47
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|December 25, 2008
[The correlation between the polyomavirus DNA load and the dose of immunosuppressant]Peng Cai, Zhi-Ping Teng, Tong Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 25, 2025
Targeted silencing of Engrailed-1 reprograms profibrotic fibroblast lineage for scarless wound healingXuehan Xu, Luyi Wang, Xinyue Bi, et al.
Biomaterials|October 24, 2006
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug deliveryJianjun Cheng, Benjamin A Teply, Ines Sherifi, et al.
Science (New York, N.Y.)|January 27, 2022
Structure-based discovery of nonhallucinogenic psychedelic analogsDongmei Cao, Jing Yu, Huan Wang, et al.
ACS Nano|February 18, 2017
Interactions between Membranes and "Metaphilic" Polypeptide Architectures with Diverse Side-Chain PopulationsMichelle W Lee, Ming Han, Guilherme Volpe Bossa, et al.
ACS Nano|January 27, 2016
Suppression of Hepatic Inflammation via Systemic siRNA Delivery by Membrane-Disruptive and Endosomolytic Helical Polypeptide Hybrid NanoparticlesHua He, Nan Zheng, Ziyuan Song, et al.
Acta Biomaterialia|March 27, 2018
BaTiO3-core Au-shell nanoparticles for photothermal therapy and bimodal imagingYanfei Wang, Aoune Barhoumi, Rong Tong, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 21, 2012
[Predictable recurrence by regular monitoring minimal residual disease with flow cytometry in the patients with both AML and ALL: a single-center study of 163 cases]Chun-rong Tong, Hui Wang, Jun-fang Yang, et al.
Zhonghua Yi Xue Za Zhi|June 26, 2009
[Major molecular response to imatinib in a patient with acute mixed lineage leukemia expressing a novel BCR/ABL transcript]Hong-xing Liu, Xing-yu Cao, Chun-rong Tong, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|June 10, 2014
CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cellsDorothea E Myers, Seang Yiv, Sanjive Qazi, et al.
Pageof 47